VYKAT XR

May 27, 2026

Since the FDA approved recombinant human growth hormone (rhGH) for Prader-Willi syndrome (PWS)  in 2000, several companies have encountered difficulties in developing more effective therapies for hyperphagia, the persistent and uncontrollable hunger associated with the disorder. However, in March 2025, Soleno ...

Apr 04, 2025

Prader-Willi Syndrome is a complex genetic disorder characterized by a variety of symptoms, including hyperphagia, obesity, and behavioral issues. According to the Prader-Willi Syndrome Association USA, the disorder affects approximately 1 in every 15,000 live births, with more than 300,000 people impacted globally...